News Agency
Men's Weekly

SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia

  • Written by PR Newswire
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia
  • The world-second developed shingles vaccine 'SKYZoster™' is approved by the National Pharmaceutical Regulatory Agency (NPRA)
  • SK biosciences plans to launch the zoster vaccine with proven efficacy and safety starting in Southeast Asian market

SEOUL, South Korea, Jan. 9, 2023 /PRNewswire/ -- SK bioscience, a global innovative vaccine and...

Read more: SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia

Insurance Industry Innovation Through VR Training

Australia's insurance industry, managing over $120 billion in annual premiums, operates at the intersection of financial services and human crisis. Insurance professionals must navigate emotionally charged situations daily, from claim denials to disaster responses. Leading insurers are now implementing best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion